Contents
Download PDF
pdf Download XML
492 Views
98 Downloads
Share this article
Research Article | Volume 13 Issue:3 (, 2023) | Pages 435 - 438
Diagnostic Utility of Immunohistochemical Markers Ck7, Ck 20 and CEA in Surface epithelial Tumors of Ovary
Under a Creative Commons license
Open Access
Received
July 5, 2023
Revised
July 19, 2023
Accepted
July 28, 2023
Published
Aug. 1, 2023
Abstract

Background: Immunohistochemistry is the definitive diagnosis in cases where a definite diagnosis cannot be made morphologically and histologically. IHC helps classify tumors. It also helps to solve the diagnosis problem of benign and malignant tumors. Material And Methods:  We studied 100 different ovarian epithelial tumors over a 2 year period. Three immune markers were included in the study. Result: Out of 100 case 70% are benign and 30%  aremalignant.Serous cystadenoma was most common benign lesion(60%)& among malignant lesions Serous cystadenocarcinoma was most common(60%).83.33% cases of serous carcinoma showed positivity for CK7 & 100% negativity for CK20 & CEA Conclusion: IHC helps to classify and confirm the histological diagnosis. IHC is particularly useful in solving the diagnostic problem of ovarian cancer and is poorly differentiated.

Keywords
Recommended Articles
Research Article
COMPARISON OF EXTUBATION OUTCOMES IN SUPINE AND SEMI FOWLER’S POSITION IN PATIENTS UNDERGOING ABDOMINAL SURGERIES – A RANDOMISED CONTROL STUDY
...
Published: 21/02/2026
Download PDF
Research Article
Comparative Evaluation of Postoperative Pain Relief following Spinal and General Anesthesia in Patients Undergoing Cholecystectomy
Published: 27/02/2014
Download PDF
Research Article
Ultrasound-Assisted Prevention of Intravascular Injection during Dermatologic AnaesthesiaUltrasound-Assisted Prevention of Intravascular Injection during Dermatologic Anaesthesia
...
Published: 30/11/2024
Download PDF
Research Article
Clinicopathological Study of Cutaneous Tumors
...
Published: 19/01/2026
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.